ZNF767P

Across TCGA pan-cancer cohorts, ZNF767P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF767P data layer compared with 26 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ZNF767P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF767P expression acts as an unfavorable survival marker.

KIRP, COAD, and ESCA are the cancer types where ZNF767P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.132	0.904	<.001	36	view →
COAD	OS	Median	All	0.001	0.871	<.001	15	view →
ESCA	DFS	Median	II,III,IV	0.107	0.522	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ZNF767P–KIRP (OS)

Open the KIRP breakdown →